KOSPI · Healthcare · ₩133B
₩8,850-0.45%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 5.9% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“이번 분기는 매출 성장보다 이익 회복이 더 중요한 시기예요.”
In the company's words · 2026 2분기 filing